Severe congenital neutropenia

Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor

Brent Weston, Robert F. Todd, Richard Axtell, Kenneth Balazovich, Jeffery Stewart, Betty J. Locey, Laura Mayo-Bond, Paul Loos, Raymond Hutchinson, Laurence A. Boxer

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.

Original languageEnglish (US)
Pages (from-to)282-290
Number of pages9
JournalThe Journal of Laboratory and Clinical Medicine
Volume117
Issue number4
StatePublished - 1991
Externally publishedYes

Fingerprint

Granulocyte Colony-Stimulating Factor
Superoxides
Neutrophils
Macrophage-1 Antigen
Transcobalamins
Complement C3b
Glucuronidase
Cytochromes
Redundancy
Therapeutics
Oral Ulcer
Neutropenia, Severe Congenital, Autosomal Recessive 3
Periodontitis
Up-Regulation
cytochrome b559
Inflammation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Weston, B., Todd, R. F., Axtell, R., Balazovich, K., Stewart, J., Locey, B. J., ... Boxer, L. A. (1991). Severe congenital neutropenia: Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. The Journal of Laboratory and Clinical Medicine, 117(4), 282-290.

Severe congenital neutropenia : Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. / Weston, Brent; Todd, Robert F.; Axtell, Richard; Balazovich, Kenneth; Stewart, Jeffery; Locey, Betty J.; Mayo-Bond, Laura; Loos, Paul; Hutchinson, Raymond; Boxer, Laurence A.

In: The Journal of Laboratory and Clinical Medicine, Vol. 117, No. 4, 1991, p. 282-290.

Research output: Contribution to journalArticle

Weston, B, Todd, RF, Axtell, R, Balazovich, K, Stewart, J, Locey, BJ, Mayo-Bond, L, Loos, P, Hutchinson, R & Boxer, LA 1991, 'Severe congenital neutropenia: Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor', The Journal of Laboratory and Clinical Medicine, vol. 117, no. 4, pp. 282-290.
Weston, Brent ; Todd, Robert F. ; Axtell, Richard ; Balazovich, Kenneth ; Stewart, Jeffery ; Locey, Betty J. ; Mayo-Bond, Laura ; Loos, Paul ; Hutchinson, Raymond ; Boxer, Laurence A. / Severe congenital neutropenia : Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. In: The Journal of Laboratory and Clinical Medicine. 1991 ; Vol. 117, No. 4. pp. 282-290.
@article{3fdcfe23c06941258ee85ff08828b42c,
title = "Severe congenital neutropenia: Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor",
abstract = "We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.",
author = "Brent Weston and Todd, {Robert F.} and Richard Axtell and Kenneth Balazovich and Jeffery Stewart and Locey, {Betty J.} and Laura Mayo-Bond and Paul Loos and Raymond Hutchinson and Boxer, {Laurence A.}",
year = "1991",
language = "English (US)",
volume = "117",
pages = "282--290",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Severe congenital neutropenia

T2 - Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor

AU - Weston, Brent

AU - Todd, Robert F.

AU - Axtell, Richard

AU - Balazovich, Kenneth

AU - Stewart, Jeffery

AU - Locey, Betty J.

AU - Mayo-Bond, Laura

AU - Loos, Paul

AU - Hutchinson, Raymond

AU - Boxer, Laurence A.

PY - 1991

Y1 - 1991

N2 - We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.

AB - We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.

UR - http://www.scopus.com/inward/record.url?scp=0025763416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025763416&partnerID=8YFLogxK

M3 - Article

VL - 117

SP - 282

EP - 290

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -